Efficiency of L-arginin in arterial hypertension

Abstract

The effectiveness of the new treatment scheme of the patients with hypertonic disease accompanied by insulin resistance by adding to the treatment L-arginine — the predecessor of nitric oxide has been examined in this work. The average duration of the research was 3 months. Including a conditionally essential amino acid L-arginine to a combined antihypertensive therapy with the help of lisinopil and amplodipine and to hypolipidemic therapy with atorvastatin had significant benefits in increasing endothelium dependent vasodilatation, decreasing HOMA-index and also in more effective correction of hypertriglyceridemia.